查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1941452

標靶蛋白分解 (TPD) 市場規模、佔有率和趨勢分析報告：按類型、應用、最終用途、地區和細分市場預測，2026-2033 年

Targeted Protein Degradation Market Size, Share & Trends Analysis Report By Type, By Application, By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

標靶蛋白分解 (TPD) 市場概述

2025 年全球標靶蛋白質分解 (TPD) 市場規模估計為 6.993 億美元，預計到 2033 年將達到 32.574 億美元。

預計從 2026 年到 2033 年，該市場將以 20.75% 的複合年成長率成長。癌症和神經退化性疾病等慢性疾病盛行率的持續上升、生活方式的改變以及醫療保健成本的上漲正在推動市場成長。

這些疾病的高發生率催生了對新型治療方法的強勁需求，推動了市場成長。擴大該領域的研發活動蘊藏著巨大的成長機會。例如，奧地利科學基金會（FWF）於2023年12月核准了標靶蛋白分解（TPD）專項研究計畫（SFB）的第二階段資助，為期四年。標靶蛋白分解（TPD）專項研究舉措旨在理解和開發靶向特定蛋白進行細胞內分解的方法。該計劃旨在推進靶向蛋白分解（TPD）領域的發展，近年來，由於其在藥物發現和治療性介入的潛在應用，該領域已引起廣泛關注。

支持性的法規環境，特別是FDA和EMA等機構簡化的核准流程，在加速標靶蛋白分解（TPD）治療方法的應用方面發揮了關鍵作用。底層技術的快速發展正在推動TPD產業的發展。諸如蛋白水解靶向嵌合體（PROTAC）、分子黏合劑和溶酶體靶向嵌合體（LYTAC）等創新方法的開發，拓展了TPD選擇性去除致病蛋白的能力。這些技術突破為標靶治療以往無法治療的蛋白開闢了新的途徑，進而推動了TPD產業的成長。

推動該產業發展的主要動力之一是人們日益認知到標靶蛋白分解 (TPD) 作為一種治療傳統難治標靶的契機。儘管傳統治療方法往往難以應對難以調控的蛋白質，但諸如蛋白水解靶向嵌合體(PROTAC) 等技術透過促進疾病相關蛋白的分解，提供了極具前景的解決方案。這種方法在癌症和神經神經退化性疾病等疾病的治療中展現出巨大的潛力，從而推動了該領域研發的蓬勃發展。近年來，美國國立衛生研究院 (NIH) 已將 PROTAC 列為關鍵藥物研發技術。臨床前和早期臨床試驗中不斷取得的成功，促使製藥和生物技術公司將標靶蛋白分解 (TPD) 納入其研發管線，因為他們認知到該技術具有變革治療策略的巨大潛力。

目錄

第1章調查方法和範圍

第2章執行摘要

3. 標靶蛋白質分解（TPD）市場變數與趨勢

  • 市場譜系展望
    • 母市場展望
    • 相關及附隨市場展望
  • 市場動態
  • 標靶蛋白分解 (TPD) 市場分析工具
    • 產業分析：波特五力模型
    • PESTEL 分析

第4章 標靶蛋白分解 (TPD) 市場：按類型分類的估算和趨勢分析

  • 全球標靶蛋白質分解 (TPD) 市場按類型分類的變異分析
  • 全球標靶蛋白分解（TPD）市場規模及趨勢分析（按類型分類，2021-2033年）
  • PROTAC
  • 分子黏合劑
  • LYTAC
  • 其他

第5章 標靶蛋白分解 (TPD) 市場：按應用分類的估算與趨勢分析

  • 按應用領域分析全球標靶蛋白分解 (TPD) 市場的變化
  • 全球標靶蛋白分解（TPD）市場規模及應用趨勢分析（2021-2033年）
  • 藥物發現
  • 藥物研發
    • 癌症
    • 神經病學
    • 感染疾病
    • 循環系統疾病
    • 其他

6. 標靶蛋白質分解 (TPD) 市場：按最終用途分類的估算和趨勢分析

  • 全球標靶蛋白質分解 (TPD) 市場按最終用途分類的差異分析
  • 全球標靶蛋白分解（TPD）市場規模及趨勢分析（依最終用途分類，2021-2033年）
  • 製藥和生物技術公司
  • 學術和研究機構
  • 醫院和臨床檢查室
  • 其他

7. 標靶蛋白分解 (TPD) 市場：區域估算與趨勢分析

  • 區域市場佔有率分析（2025 年和 2033 年）
  • 區域市場概覽
  • 市場規模及預測趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭情勢

  • 公司/競爭對手分類
  • 策略規劃
  • 2025年商業市場分析
  • 公司簡介/列表
    • Bayer AG
    • Bio-Techne
    • BOC Sciences
    • BPS Bioscience, Inc.
    • BroadPharm
    • LifeSensors Inc.
    • MedChemExpress.
    • Merck KGaA
    • Promega Corporation
    • Thermo Fisher Scientific, Inc.
Product Code: GVR-4-68040-351-3

Targeted Protein Degradation Market Summary

The global targeted protein degradation market size was estimated at USD 699.3 million in 2025 and is projected to reach USD 3,257.4 million by 2033, growing at a CAGR of 20.75% from 2026 to 2033. The constantly growing frequency of chronic disease conditions such as cancer and neurodegenerative diseases, along with changing lifestyles and increasing healthcare spending, is accelerating the market growth.

The high prevalence of these diseases creates a strong demand for novel treatment options, driving market growth. The expanding number of research and development activities in this field provides significant market growth opportunities. For instance, in December 2023, the Austrian Science Fund (FWF) approved the Special Research Program (SFB) in Targeted Protein Degradation for a second funding period of another four years. The SFB in targeted protein degradation is a research initiative focusing on understanding and developing methods to target specific proteins for cell degradation. This program aims to advance the field of targeted protein degradation, which has gained significant attention in recent years due to its potential applications in drug discovery and therapeutic interventions.

The supportive regulatory environment, particularly the streamlined approval processes by agencies such as the FDA and EMA, has played a crucial role in accelerating the adoption of TPD-based therapies. Rapid advancements in the underlying technologies drive the targeted protein degradation industry. The development of innovative approaches, such as proteolysis-targeting chimeras (PROTACs), molecular glues, and lysosome-targeting chimeras (LYTACs), has expanded TPD's capabilities to eliminate disease-causing proteins selectively. These technological breakthroughs have opened up new avenues for targeting previously undruggable proteins, driving the growth of the targeted protein degradation industry.

The increasing recognition of the therapeutic potential of targeted protein degradation in addressing previously undruggable targets is a key driver for the targeted protein degradation industry. Traditional approaches often struggle with proteins that are difficult to modulate, but technologies such as PROTACs (proteolysis-targeting chimeras) provide a favorable solution by promoting the degradation of disease-causing proteins. This method has shown considerable promise in treating conditions such as cancer and neurodegenerative disorders, sparking a surge in research and investment in this area. The National Institute of Health highlights PROTACs as a leading drug development technology in recent years. The increasing success in preclinical and early-phase clinical trials drives pharmaceutical and biotech companies to integrate targeted protein degradation into their pipelines, recognizing its potential to transform therapeutic strategies.

Global Targeted Protein Degradation Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global targeted protein degradation market report based on type, application, end use, and region:

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • PROTAC
  • Molecular Glues
  • LYTACs
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Drug Discovery
  • Therapy Development
    • Cancer
    • Neurology
    • Infectious Diseases
    • Cardiovascular Diseases
    • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Hospitals & Clinical Laboratories
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Type Segment
    • 1.2.2. Application Segment
    • 1.2.3. End Use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Targeted Protein Degradation Market Variables & Trends

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing frequency of chronic diseases
      • 3.2.1.2. Research and development activities
      • 3.2.1.3. Increasing recognition of the therapeutic potential of targeted protein degradation
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Stringent regulations associated with approvals for novel TPD based therapies
  • 3.3. Targeted Protein Degradation Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. Targeted Protein Degradation Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Targeted Protein Degradation Market Type Movement Analysis
  • 4.3. Global Targeted Protein Degradation Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
  • 4.4. PROTAC
    • 4.4.1. PROTAC market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5. Molecular Glues
    • 4.5.1. Molecular Glues market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.6. LYTACs
    • 4.6.1. LYTACs market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.7. Others
    • 4.7.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Targeted Protein Degradation Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Targeted Protein Degradation Market Application Movement Analysis
  • 5.3. Global Targeted Protein Degradation Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 5.4. Drug Discovery
    • 5.4.1. Drug Discovery market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. Therapy Development
    • 5.5.1. Therapy Development market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.5.2. Cancer
      • 5.5.2.1. Cancer market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.5.3. Neurology
      • 5.5.3.1. Neurology market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.5.4. Infectious Diseases
      • 5.5.4.1. Infectious Diseases market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.5.5. Cardiovascular Diseases
      • 5.5.5.1. Cardiovascular Diseases market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.5.6. Others
      • 5.5.6.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Targeted Protein Degradation Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Targeted Protein Degradation Market End Use Movement Analysis
  • 6.3. Global Targeted Protein Degradation Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 6.4. Pharmaceutical & Biotechnology Companies
    • 6.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5. Academic & Research Institutes
    • 6.5.1. Academic & Research Institutes market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6. Hospitals & Clinical Laboratories
    • 6.6.1. Hospitals & Clinical Laboratories market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7. Others
    • 6.7.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Targeted Protein Degradation Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2025 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 7.4. North America
    • 7.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Competitive scenario
      • 7.4.2.3. Regulatory framework
      • 7.4.2.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Competitive scenario
      • 7.4.3.3. Regulatory framework
      • 7.4.3.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Competitive scenario
      • 7.4.4.3. Regulatory framework
      • 7.4.4.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5. Europe
    • 7.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Competitive scenario
      • 7.5.2.3. Regulatory framework
      • 7.5.2.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Competitive scenario
      • 7.5.3.3. Regulatory framework
      • 7.5.3.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Competitive scenario
      • 7.5.4.3. Regulatory framework
      • 7.5.4.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Competitive scenario
      • 7.5.5.3. Regulatory framework
      • 7.5.5.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Competitive scenario
      • 7.5.6.3. Regulatory framework
      • 7.5.6.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.7. Norway
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Competitive scenario
      • 7.5.7.3. Regulatory framework
      • 7.5.7.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Competitive scenario
      • 7.5.8.3. Regulatory framework
      • 7.5.8.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.9. Denmark
      • 7.5.9.1. Key country dynamics
      • 7.5.9.2. Competitive scenario
      • 7.5.9.3. Regulatory framework
      • 7.5.9.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Regulatory framework
      • 7.6.2.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. Regulatory framework
      • 7.6.3.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Competitive scenario
      • 7.6.4.3. Regulatory framework
      • 7.6.4.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Competitive scenario
      • 7.6.5.3. Regulatory framework
      • 7.6.5.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Competitive scenario
      • 7.6.6.3. Regulatory framework
      • 7.6.6.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Competitive scenario
      • 7.6.7.3. Regulatory framework
      • 7.6.7.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Regulatory framework
      • 7.7.2.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Regulatory framework
      • 7.7.3.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.8. Middle East and Africa
    • 7.8.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Competitive scenario
      • 7.8.2.3. Regulatory framework
      • 7.8.2.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Competitive scenario
      • 7.8.3.3. Regulatory framework
      • 7.8.3.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Competitive scenario
      • 7.8.4.3. Regulatory framework
      • 7.8.4.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key country dynamics
      • 7.8.5.2. Competitive scenario
      • 7.8.5.3. Regulatory framework
      • 7.8.5.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2025
  • 8.4. Company Profiles/Listing
    • 8.4.1. Bayer AG
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Type benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Bio-Techne
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Type benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. BOC Sciences
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Type benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. BPS Bioscience, Inc.
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Type benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. BroadPharm
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Type benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. LifeSensors Inc.
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Type benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. MedChemExpress.
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Type benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Merck KGaA
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Type benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Promega Corporation
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Type benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Thermo Fisher Scientific, Inc.
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Type benchmarking
      • 8.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global Targeted protein degradation market, by region, 2021 - 2033 (USD Million)
  • Table 3 Global Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 4 Global Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 5 Global Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 6 North America Targeted protein degradation market, by country, 2021 - 2033 (USD Million)
  • Table 7 North America Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 8 North America Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 9 North America Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 10 U.S. Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 11 U.S. Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 12 U.S. Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 13 Canada Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 14 Canada Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 15 Canada Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 16 Mexico Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 17 Mexico Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 18 Mexico Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 19 Europe Targeted protein degradation market, by country, 2021 - 2033 (USD Million)
  • Table 20 Europe Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 21 Europe Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 22 Europe Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 23 Germany Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 24 Germany Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 25 Germany Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 26 UK Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 27 UK Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 28 UK Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 29 France Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 30 France Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 31 France Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 32 Italy Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 33 Italy Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 34 Italy Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 35 Spain Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 36 Spain Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 37 Spain Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 38 Denmark Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 39 Denmark Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 40 Denmark Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 41 Sweden Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 42 Sweden Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 43 Sweden Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 44 Norway Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 45 Norway Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 46 Norway Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific Targeted protein degradation market, by country, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 51 China Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 52 China Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 53 China Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 54 Japan Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 55 Japan Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 56 Japan Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 57 India Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 58 India Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 59 India Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 60 South Korea Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 61 South Korea Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 62 South Korea Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 63 Australia Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 64 Australia Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 65 Australia Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 66 Thailand Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 67 Thailand Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 68 Thailand Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 69 Latin America Targeted protein degradation market, by country, 2021 - 2033 (USD Million)
  • Table 70 Latin America Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 71 Latin America Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 72 Latin America Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 73 Brazil Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 74 Brazil Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 75 Brazil Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 76 Argentina Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 77 Argentina Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 78 Argentina Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 79 Middle East and Africa Targeted protein degradation market, by country, 2021 - 2033 (USD Million)
  • Table 80 Middle East and Africa Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 81 Middle East and Africa Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 82 Middle East and Africa Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 83 South Africa Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 84 South Africa Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 85 South Africa Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 86 Saudi Arabia Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 89 UAE Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 90 UAE Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 91 UAE Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 92 Kuwait Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 93 Kuwait Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 94 Kuwait Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Targeted protein degradation market: Market outlook
  • Fig. 5 Targeted protein degradation market: Segment outlook
  • Fig. 6 Targeted protein degradation market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Targeted protein degradation market driver impact
  • Fig. 9 Targeted protein degradation market restraint impact
  • Fig. 10 Targeted protein degradation market: Type outlook and key takeaways
  • Fig. 11 Targeted protein degradation market: Type movement analysis
  • Fig. 12 PROTAC market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 13 Molecular glues market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 14 LYTACs market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 15 Others market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 16 Targeted protein degradation market: Application outlook and key takeaways
  • Fig. 17 Targeted protein degradation market: Application movement analysis
  • Fig. 18 Drug discovery market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 19 Therapy development market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 20 Cancer market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 21 Neurology market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 22 Infectious diseases market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 23 Cardiovascular diseases market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 24 Others market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 25 Targeted protein degradation market: End Use outlook and key takeaways
  • Fig. 26 Targeted protein degradation market: End Use movement analysis
  • Fig. 27 Pharmaceutical & biotechnology companies market estimates and forecasts,2021 - 2033 (USD Million)
  • Fig. 28 Academic & research institutes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Hospitals & clinical laboratories market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Global Targeted protein degradation market: Regional outlook and key takeaways
  • Fig. 32 Global Targeted protein degradation market: Regional movement analysis
  • Fig. 33 North America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Key country dynamics
  • Fig. 35 U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Target Disease Prevalence
  • Fig. 37 Key country dynamics
  • Fig. 38 Canada market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Target Disease Prevalence
  • Fig. 40 Key country dynamics
  • Fig. 41 Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Target Disease Prevalence
  • Fig. 43 Europe market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 UK market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Target Disease Prevalence
  • Fig. 47 Key country dynamics
  • Fig. 48 Germany market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Target Disease Prevalence
  • Fig. 50 Key country dynamics
  • Fig. 51 France market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Target Disease Prevalence
  • Fig. 53 Key country dynamics
  • Fig. 54 Italy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Target Disease Prevalence
  • Fig. 56 Key country dynamics
  • Fig. 57 Spain market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Target Disease Prevalence
  • Fig. 59 Key country dynamics
  • Fig. 60 Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Target Disease Prevalence
  • Fig. 62 Key country dynamics
  • Fig. 63 Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Target Disease Prevalence
  • Fig. 65 Key country dynamics
  • Fig. 66 Norway market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Target Disease Prevalence
  • Fig. 68 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 China market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Target Disease Prevalence
  • Fig. 72 Key country dynamics
  • Fig. 73 Japan market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Target Disease Prevalence
  • Fig. 75 Key country dynamics
  • Fig. 76 India market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 Target Disease Prevalence
  • Fig. 78 Key country dynamics
  • Fig. 79 Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 Target Disease Prevalence
  • Fig. 81 Key country dynamics
  • Fig. 82 South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 Target Disease Prevalence
  • Fig. 84 Key country dynamics
  • Fig. 85 Australia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 86 Target Disease Prevalence
  • Fig. 87 Latin America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 90 Target Disease Prevalence
  • Fig. 91 Key country dynamics
  • Fig. 92 Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 93 Target Disease Prevalence
  • Fig. 94 Middle East and Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 97 Target Disease Prevalence
  • Fig. 98 Key country dynamics
  • Fig. 99 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 100 Target Disease Prevalence
  • Fig. 101 Key country dynamics
  • Fig. 102 UAE market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 103 Target Disease Prevalence
  • Fig. 104 Key country dynamics
  • Fig. 105 Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 106 Target Disease Prevalence